| RS2038702746 |
CEP290
|
Health Risk |
Likely pathogenic |
Bardet-Biedl syndrome 14, Meckel-Gruber syndrome |
| RS2038702963 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038706856 |
PTPN11
|
Health Risk |
Likely pathogenic |
Noonan syndrome 1, Noonan syndrome 1 |
| RS2038713813 |
PTPN11
|
Health Risk |
Likely pathogenic |
RASopathy, RASopathy |
| RS2038715253 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2038723552 |
ZFHX3
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS2038731369 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038736631 |
DNMT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory neuropathy-deafness-dementia syndrome, Inborn genetic diseases |
| RS2038744386 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038752283 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2038760864 |
CFAP298
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 26, Primary ciliary dyskinesia 26 |
| RS2038770461 |
ZFYVE26
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 15, Hereditary spastic paraplegia 15 |
| RS2038778316 |
GYS1
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, Glycogen storage disease |
| RS2038785200 |
ABCC2
|
Health Risk |
Likely pathogenic |
— |
| RS2038788369 |
ABCC2
|
Health Risk |
Pathogenic/Likely pathogenic |
Dubin-Johnson syndrome, Dubin-Johnson syndrome |
| RS2038821887 |
ABCC2
|
Health Risk |
Pathogenic |
— |
| RS2038825509 |
CLCN7
|
Health Risk |
Pathogenic |
Autosomal dominant osteopetrosis 2, CLCN7-related disorder |
| RS2038838513 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2038844292 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038844790 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038850050 |
CLCN7
|
Health Risk |
Likely pathogenic |
— |
| RS2038865240 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2038884150 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038909213 |
USH1G
|
Health Risk |
Pathogenic |
— |
| RS2038915208 |
CEP290
|
Health Risk |
Likely pathogenic |
Joubert syndrome, Nephronophthisis |
| RS2038919221 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2038922133 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS2038926434 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2038930076 |
USH1G
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS2038940533 |
LOXHD1
|
Health Risk |
Likely pathogenic |
— |
| RS2038943096 |
ATCAY
|
Health Risk |
Pathogenic |
— |
| RS2038953746 |
CFAP298
|
Health Risk |
Pathogenic |
— |
| RS2038967116 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038967261 |
FANCA
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038967521 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038968872 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038969261 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2038969615 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2038978870 |
MTM1
|
Health Risk |
Likely pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2038979352 |
MTM1
|
Health Risk |
Pathogenic |
Severe X-linked myotubular myopathy, Severe X-linked myotubular myopathy |
| RS2038987366 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
POLD1-related disorder, POLD1-related disorder |
| RS2038999395 |
ETFA
|
Health Risk |
Likely pathogenic |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039024047 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039038743 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039038796 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039040448 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039041225 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039042313 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039044722 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039058807 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039062513 |
ZFYVE26
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 15, Spastic paraplegia |
| RS2039064081 |
ETFA
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Multiple acyl-CoA dehydrogenase deficiency |
| RS2039074823 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039075542 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039076227 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2039077331 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia |
| RS2039077507 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039078843 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2039079300 |
FANCA
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group A, Fanconi anemia complementation group A |
| RS2039098098 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039109372 |
MEGF8
|
Health Risk |
Likely pathogenic |
MEGF8-related Carpenter syndrome, MEGF8-related Carpenter syndrome |
| RS2039109846 |
CHSY1
|
Health Risk |
Pathogenic |
Temtamy preaxial brachydactyly syndrome, Temtamy preaxial brachydactyly syndrome |
| RS2039116471 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039117815 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039118159 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039119649 |
TTC21A
|
Health Risk |
Likely pathogenic |
TTC21A-related disorder, TTC21A-related disorder |
| RS2039119852 |
SLC24A5
|
Health Risk |
Likely pathogenic |
— |
| RS2039120342 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2039122730 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039131123 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039141441 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039143109 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2039146031 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039149745 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039150286 |
GAA
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type II |
| RS2039153749 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039156731 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia |
| RS2039157751 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039158032 |
FANCA
|
Health Risk |
Pathogenic |
Fanconi anemia, Fanconi anemia complementation group A |
| RS2039161082 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2039181631 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2039190879 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039191420 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039191855 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2039192386 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2039192921 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039195145 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039198631 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS2039204524 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Meckel-Gruber syndrome, Nephronophthisis |
| RS2039208042 |
ATL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 3A, Hereditary spastic paraplegia 3A |
| RS2039212985 |
GAA
|
Health Risk |
Likely pathogenic |
Glycogen storage disease, type II |
| RS2039213824 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039215098 |
GAA
|
Health Risk |
Pathogenic |
— |
| RS2039216097 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039216816 |
GAA
|
Health Risk |
Likely pathogenic |
— |
| RS2039217093 |
GAA
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease, type II |
| RS2039218006 |
CEP290
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS2039222879 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS2039228359 |
ZFYVE26
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS2039235887 |
ADAMTS17
|
Health Risk |
Likely pathogenic |
— |